Risk Factors and Adverse Events Poorly Predict Infections and Hypogammaglobulinemia in Granulomatosis with Polyangiitis Patients Receiving Rituximab

Figure 4

Redundancy analysis of the five predictors using the two best combinations of outcomes. values and squared of each predictor are presented in the included table. Age: age in years at rituximab initiation; CYC: cyclophosphamide cumulative dose; Gpr: gram of RTX per round; Ig: total level of immunoglobulin prior rituximab; Rat: ratio CD4/CD8 prior rituximab; severe I: severe infection.